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Abstract
Objective—The caudate nucleus (CN) is a crucial component of the ventral striatum, which is
part of a prefrontal-striatal-thalamic circuit that is modulated by limbic structures to subserve
emotional processing. Bipolar disorder is thought to be underpinned by dysfunctional anterior
limbic networks, although MRI studies examining the CN have shown equivocal results. As gross
volumetric analyses may not detect subtle regional change, we aimed to clarify the role of the CN
in bipolar disorder by undertaking shape analysis to detect regional reductions.
Methods—The CN was manually traced on MRI scans from 27 patients with bipolar-I disorder
and 24 matched controls. A non-parametric spherical harmonic shape analysis was undertaken
using the SPHARM toolkit.
Results—Whilst the left CN volume was consistently larger in the sample, there was no effect of
group or gender or significant interactions between these variables. Volume did not correlate with
illness duration or lithium dosage, but was larger in those with a history of psychosis at trend
level. However, left caudate shape differed significantly between groups, with deflation in an area
along the ventromedial surface (connecting to dorsolateral prefrontal regions) in bipolar patients.
Psychotic patients showed increases in the dorsal head and body at trend level overall, in regions
connecting to medial and orbitofrontal regions.
Conclusions—These findings suggest that subtle rather than gross structural changes occur in
the CN, which may not be detectable by volumetric analysis alone, and reflect alterations in
specific frontostriatal circuitry in the disorder.
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The basal ganglia (BG) are a paired group of nuclei interconnected with the cerebral cortex,
thalamus and brainstem. They have been implicated in a variety of processes, including
associative, cognitive, mnemonic and motor functions (Slaght et al., 2002). More recently,
understanding the complexity in structure, neurochemical interaction and anatomical
interrelationships with the thalamus and cortex has led to an understanding of its central
influence on executive function, emotion and cognitive behaviours (Alexander and Crutcher,
1990). Within this, the caudate nucleus (CN) is known for its role in higher-order motor
control, and more recently learning and memory, particularly feedback processing (Packard
and Knowlton, 2002). Mounting evidence suggests that emotional processing is linked to
anatomically defined networks consisting of limbic structures that modulate iterative
prefrontal-striatal-thalamic circuits (Szily and Keri, 2008). The ventral striatum, which
includes the CN, is known to play a crucial role in this network (Lehericy et al., 2004).
Bipolar affective disorder (BPAD) is a DSM-IV axis-I mood disorder that confers
considerable individual and societal morbidity and cost (Gardner et al., 2006). A significant
body of evidence suggests that BPAD has a strong neurobiological basis that involves
dysfunction of the anterior limbic brain networks, which include the BG (Strakowski et al.,
2005). Specifically, metabolic (Baxter et al., 1985; Blumberg et al., 2000; O’Connell et al.,
1995) and monoaminergic receptor (Pearlson et al., 1995) changes have been identified in
the BG of BPAD patients, and medications routinely used to treat the illness, such as lithium
and valproate, have been shown to alter the anatomy of the limbic system (Foland et al.,
2007; Yucel et al., 2008). Antipsychotic medications, also used in the treatment of BPAD,
block dopamine receptors in the BG (Miklowitz and Johnson, 2006), and are known to
affect the size of structures within the BG (Chakos et al., 1994; Gur et al., 1998). However,
the findings from these studies have been marked by a great degree of heterogeneity, as a
result of small sample sizes, cross-sectional design and differing mood states in patients at
the time of assessment (Langan and McDonald, 2009).
Structural magnetic resonance imaging (MRI) studies have been increasingly utilised to
characterise in vivo brain changes in bipolar patients (Malhi et al., 2002; Strakowski et al.,
1999, 2005), albeit with similarly heterogeneous results (Arnone et al., 2009). The most
robust findings have been enlargement of the lateral ventricles (Andreasen et al., 1990;
Dewan et al., 1988; Nasrallah et al., 1982; Pearlson et al., 1984a, 1984b) and reduction in
volume of the prefrontal cortex (Coffman et al., 1990; Lavretsky et al., 2004; Sax et al.,
1999). In the limbic system, while some studies report enlarged amygdalae in BPAD
(Altshuler et al., 2000; Frangou, 2005; Strakowski et al., 1999), some suggest overall
volume reduction, or reduction in only one side (Blumberg et al., 2003; Chang et al., 2005b;
Pearlson et al., 1997). Most, but not all, studies (Blumberg et al., 2003; Swayze et al., 1992)
have failed to demonstrate volumetric change in the hippocampus (Altshuler et al., 2000;
Blumberg et al., 2003; Chang et al., 2005b; Noga et al., 2001; Pearlson et al., 1997; Sax et
al., 1999; Strakowski et al., 1999). The heterogeneity of neuroimaging findings in BPAD
has largely been attributed to clinical and treatment, rather than imaging, variables (Arnone
et al., 2009). Thus, in a recent meta-analysis of voxel-based morphometry studies, which
identified reduced grey matter in anterior cingulate and fronto-insular regions, longer illness
duration was associated with increased grey matter in the BG, subgenual anterior cingulate
cortex and amygdala, and lithium treatment was associated with increased anterior cingulate
cortex volume (Bora et al., 2010).
MRI studies of the BG have also been equivocal. While one early study suggested that
lateral ventricular enlargement was a consequence of periventricular atrophy of structures
such as the CN (Strakowski et al., 2002), most early studies failed to find a difference
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between BPAD patients and controls (Brambilla et al., 2001; Harvey et al., 1994;
Strakowski et al., 1993; Swayze et al., 1992). Aylward et al. (1994) found bilaterally larger
caudate volumes in male bipolar patients, but could not rule out the effects of comorbidity or
medication. Strakowski et al. (1999) found striatal enlargement in BPAD patients compared
to controls, with no association between medication exposure and enlargement. More recent
studies have provided mixed results, with some suggesting CN size increases (DelBello et
al., 2004; Noga et al., 2001; Strakowski et al., 2002), but others finding no differences
between BPAD patients and controls (Beyer et al., 2004; Chang et al., 2005a; Sanches et al.,
2005; Sax al., 1999). When juvenile samples haveet been examined, no volumetric changes
have been demonstrated in CN and other BG nuclei (Ahn et al., 2007; Chang et al., 2005b;
Sanches et al., 2005). The only study looking at older patients showed a reduction in right
CN volume compared to controls after controlling for age and gender, suggesting an illness
by age interaction at the level of the BG that may not be apparent in younger patients (Beyer
et al., 2004). Few studies have controlled for medication when examining brain volumes in
BPAD. Mood stabilisers such as lithium may demonstrate a neuroprotective effect (Rowe
and Chuang, 2004; Young et al., 2002) and some region of interest (ROI) studies have found
larger volumes in medicated subjects, or smaller volumes in drug-naïve patients (Foland et
al., 2007; Frangou, 2005; Hwang et al., 2006; Wilke et al., 2004), including a differential
effect of drug treatment on the shape of the CN in bipolar patients (Hwang et al., 2006). This
was the only study to look at shape of the CN in BPAD and found that, whilst overall
volume did not differ, significant shape changes were seen on anterior and ventral surfaces,
particularly on the right side, and were only seen in drug-naïve bipolar patients (Hwang et
al., 2006). This study suggested that examining shape in three dimensions, rather than
measuring volume alone, may reveal subtle differences affecting structure and/or
development of the CN in BPAD. A recent summary of functional and structural studies in
BPAD noted that bipolar disorder is generally associated with striatal overactivity at a
functional level, whereas structural findings have been mixed and that the most likely reason
for this variability is the use of antipsychotic medication, which affect striatal volume
(Marchand and Yurgelun-Todd, 2010).
We aimed to expand on this dataset, particularly the findings of Hwang et al. (2006), by
examining a group of established BPAD-I patients who were scanned when euthymic,
antipsychotic-free for at least one year, using an established caudate tracing protocol, and
examining shape using a sophisticated non-parametric shape analysis. We hypothesised that
shape differences would exist when comparing bipolar patients to controls, regionalised
pathology in the ventral CN, and that patients not treated with lithium would show
reductions in this area compared to lithium-treated patients.
Methods
Subjects
Twenty-seven patients (Table 1) with BPAD-I were recruited from a specialist Mood
Disorders Clinic in Sydney, Australia. Diagnoses were made by a research psychiatrist using
the DSM-IV SCID-P (First et al., 1998), supplemented by case note review.
The family history of bipolar and unipolar affective disorder is summarised in Table 1.
Medication history is also described in Table 1; the patient whose medication status was
unknown was excluded from medication analysis. All other patients were previously
exposed to antipsychotic medication, although none within 12 months of entering the study.
Twenty-four controls were recruited via advertisement and matched for age and education.
They were screened for a personal and family history of psychiatric or neurological disorder
using the SCIP-NP. Participants were excluded if they had a history of ongoing substance
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misuse, neurological disease or, in patients, a comorbid axis I or II DSM-IV diagnosis
requiring treatment. All participants were right-handed. All participants provided written,
informed consent prior to participating and the study had Prince of Wales Hospital and
University of New South Wales ethics committee permission.
MRI acquisition and pre-processing
Scans were acquired on a 1.5 T GE Signa scanner located at the Royal Prince Alfred
Hospital, Sydney, Australia. Imaging parameters were: echo time (TE), 5.3 ms; repetition
time (TR), 12.2 ms; field of view, 24.9 cm; voxel dimensions, 0.977 × 0.977 × 1.6 mm thick
coronal slices. All MRI data were transferred from CD to a Linux Debian 3.1 workstation
and coded to ensure participant confidentiality and blinded rating.
Each participant’s image was stripped of extracerebral tissue (Smith, 2002) and aligned to
the N27 template (Holmes et al., 1998) via a six-degree rigid-body transformation
(Jenkinson and Smith, 2001) using tools contained in the FSL software package
(www.fmrib.ox.ac.uk/fsl). No re-scaling or warping was performed, but the images were
resampled to 1 mm3 voxels in the process.
Volumetric measures
Intracranial volume—Intracranial volume (ICV) was measured by manual tracing using
the dura mater as the major anatomical boundary. Where the dura mater was not visible, the
cerebral contour was outlined. Other landmarks were the under-surfaces of the frontal lobe,
the dorsum sellae, clivus, and the attachment of the dura to the posterior cutting across to the
anterior arch of CI at the cranio-vertebral junction. Both inter- and intrarater correlation
coefficient measurements were 0.99 for 10 randomly selected images (Eritaia et al., 2000).
CN volume—The methodology for caudate volume used in this study has been previously
described (Hannan et al., 2010). Briefly, whole brain images were first aligned using a 6-
parameter transformation to the Montreal Neurological Institute (MNI) image using the
automated FLIRT (FMRIB’s Linear Image Registration Tool) from the FSL toolbox
(Jenkinson and Smith, 2001; Jenkinson et al., 2002). Images were re-sliced isotropically (1.0
mm3). Manual tracing of CN volumes was then done using ANALYZE 7.2 (MAYO Clinic,
USA) software. Left and right caudate perimeters were traced manually on each contiguous
1.0 mm thick coronal slice. The slices were aligned with the plane perpendicular to the line
between the anterior and posterior commissure. The lateral ventricle was used to define the
anterior, posterior, medial and superior boundaries of the CN (Figure 1). Dorsally, the
caudate is easily demarcated from the white matter that surrounds it – as such, the traces
continued posteriorly and anteriorly until the caudate was no longer visible in the slice.
Inferiorly, the caudate shares borders with the striaterminalis and the nucleus accumbens.
The caudate has been shown to perform distinct functional roles and have different
neuroconnectivity from the nucleus accumbens (Parent and Hazrati, 1995) so it was
important to exclude it in the traces. For tracing purposes, the nucleus accumbens was
demarcated by a line connecting the inferior margin of the lateral ventricle with the inferior
border of the internal capsule, bordering with the caudate from the slice most anterior where
the putamen appeared as a distinct entity to the slice most posterior where the internal
capsule extends past the inferior point of the lateral ventricle. There are cell bridges between
the putamen and caudate; these were traced to their midpoint when the voxel resolution
allowed. Seven randomly selected images were measured twice to establish inter- and
intrarater reliability, which were calculated using an intraclass correlation coefficient (ICC;
model 3, two-way mixed). Interrater ICC reliabilities were 0.919 (right) and 0.803 (left).
Intrarater ICC reliabilities were 0.907 (right) and 0.945 (left).
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CN shape—Shape analysis was undertaken in a semi-automated fashion using the
University of North Carolina shape analysis toolkit (Styner et al., 2006)
(www.nitrc.org/projects/spharm-pdm). Segmented 3D label maps were initially processed to
ensure interior holes were filled, followed by morphological closing and minimal
smoothing. These were then subjected to spherical harmonic shape description (SPHARM-
PDM), with reconstructed boundary surfaces of all segmentations mapped onto the unit
sphere and described via a set of coefficients weighting spherical harmonic basis functions.
The correspondence between surfaces was established by a parameter-space rotation based
on the first-order expansion of the spherical harmonics. All surfaces were then uniformly
sampled into sets of 1002 surface points each. These surfaces were then aligned to a study-
averaged template for each structure (left and right caudate and putamen) using rigid-body
Procrustes alignment (Bookstein, 1997), with normalisation for head size using ICV with a
scaling factor, fi, where fi = (mean(ICV)/ICVi)1/3.
Statistical analysis
No data needed to be excluded for any reason. Data was analysed using SPSS 15.0 for
Windows. Alpha level was set to 0.05 for all tests. Comparison was made between the
bipolar-I group (BPAD-I) and the healthy controls (HC). Another comparison was made
between the BPAD-I, this time separated on the basis of history of psychosis, and HC, in the
same manner. Demographic data were compared using χ2 analyses for categorical data
(gender, family history), independent-samples t-tests for age, current IQ, education level in
years, intracranial and caudate volumes, with Levene’s test for equality of variance being
applied to determine the appropriate t-test. Repeated-measures analysis of variance was used
to test for interaction effects by hemisphere within subjects and gender and diagnosis
between subjects. Pearson’s correlation was used to investigate correlations between volume
and duration of illness, lithium dosage and valproate dosage.
To compare structural shape between BPAD-I patients and controls, we computed the local
Hotelling T2 two-sample mean difference, and corrected for multiple comparisons using
false discovery rate (FDR) (Genovese et al., 2002). We generated mean difference
magnitude displacement maps and significance maps of the local p-values in raw format,
and corrected for multiple comparisons (Figure 2). We also computed an overall, global
shape difference via averaging the local group differences across the whole surface. In
addition, we performed a shape-based correlation analysis. This was done by first computing
local surface normals (perpendicular vector to the surface) on the average surface across all
datasets. Then the local difference vector from each individual surface to that average was
projected onto the normal, thus deriving a single scalar value representing the shape
difference of the individual shape to the average surface along the normal (Styner et al.,
2006). These values were then correlated with illness variables based on Spearman’s rank-
order correlation. Raw and corrected p-values were calculated as per group differences, and
displacement and significance maps were generated (Figure 2).
Results
Table 1 shows the demographic features between groups. There were no differences in age,
gender balance, premor-bid IQ or level of education.
The raw volumetric data of the ICV, right and left caudate nucleus volume (CNV) are
shown in Table 2. The ICV was well matched between groups. There was no statistically
significant overall difference between left and right CNV between groups.
Repeated-measures analysis of variance was undertaken to examine the effect of gender and
laterality on CNV in these groups, with hemisphere as the within-subject factor and gender
Ong et al. Page 5













and diagnosis as between-subject factors. There was a significant effect of hemisphere (left
> right; F(1,47) = 13.36, p = 0.001). However, there was no significant effect of group
(F(1,47) = 0.221, p = 0.803), and no significant interactions (hemisphere by gender, F(1,47) =
2.615, p = 0.113; hemisphere by diagnosis, F(1,47) = 0.244, p = 0.624; hemisphere by
diagnosis by gender, F(1,47) = 0.100, p = 0.753).
There was no correlation with illness duration (pright = 0.147, pleft = 0.227), lithium dosage
(n = 12, pright = 0.509; pleft = 0.456) or valproate dosage (n = 12; pright = 0.911, pleft =
0.928). Left and right CNV correlated strongly with each other (r = 0.908, p < 0.001), and
the strength of this correlation did not differ between the groups (z = 0.826, p = 0.409).
There was a negative correlation between CNV and age that reached trend levels in the
sample as a whole (rright = −0.264, pright = 0.056; rleft = −0.272, pleft = 0.064), although
when the BPAD and HC groups were compared, correlation coefficients remained similar,
but analyses became non-significant. These correlation coefficients did not differ however
between the two groups, suggesting that this loss of significant correlation may have related
to sample size (zleft = 0.182, pleft = 0.855; zleft = 0.206; pleft = 0.837).
Comparisons were also made between the HC group, patients with a history of psychosis
(BPAD-P) and those without (BPAD-NP). A repeated-measures analysis was conducted to
investigate the effect of a history of psychotic symptoms, using left and right CNV as
within-subject factors and group and gender as between-subject factors. There was an
overall trend for a between-group effect for a larger caudate in those with a psychotic history
(F(1,47) = 2.56, p = 0.09); there was no significant effect of gender, or other interaction
effects [group by gender (F(1,47) = 0.73, p = 0.49), hemisphere, hemisphere by gender,
hemisphere by group (F(1,47) = 0.92, p = 0.59), or hemisphere by group by gender (F(1,47) =
1.02, p = 0.32) effects.
When shape was analysed, there was an overall significant shape difference in the left
caudate (bipolar patients showing reductions compared to controls, average p-value across
surface = 0.028), with regions of significant shape difference that survived FDR correction
localised along the ventromedial surface (Figure 3, Table 3). There was no significant
overall shape difference on the right (Figure 4). When psychotic and non-psychotic groups
were compared, there was a trend towards an overall significant shape difference in the left
caudate (non-psychotic deflated compared to psychotic; average p-value across surface =
0.096, Figure 5), with areas on the dorsal body and head that did not survive FDR
correction; there was no overall significant shape difference in the right caudate (Figure 6).
When the lithium-treated bipolar patients were compared to those not on lithium treatment,
there were no significant shape difference in the left or right caudate nuceli (Table 3).
Discussion
In this paper we used a manual tracing protocol to compare the volumes and shapes of CN in
patients with BPAD-I and controls matched for age, sex and education. We found that while
there was no significant difference in volume between these groups, there was a small
regional shape difference in the bipolar group, with a reduction in the ventral region of the
body of the left caudate. This region has been demonstrated to connect to dorsolateral and
medial prefrontal cortex and orbitofrontal cortex via primate tracing studies (Haber et al.,
2000) and diffusion-tensor imaging tractography studies in humans (Draganski et al., 2008;
Leh et al., 2007). Cortical connections from ventral caudate overlap considerably with those
from the dorsal region (Draganski et al., 2008). The frontal-subcortical loops that pass
through the ventral caudate include the medial prefrontal loop that connects ventral caudate
to the anterior cingulate, and state-related hyperactivity in this circuit has been described in
bipolar mania (Blumberg et al., 2000).
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CN volumes tended to decrease with age as has been described in healthy controls (Passe et
al., 1997), and there were no significant differences in this effect between controls and the
BPAD-I group, suggesting no age-by-illness interaction. There were no statistically
significant correlations with caudate measures and clinical variables, including age of onset,
family history, number of manic or depressive episodes, or medication dosage. However,
there was a trend to smaller caudate nuclei in BPAD-I patients with no history of psychosis
compared to BPAD-I patients with a history of psychosis, with the trend being stronger for
the right caudate than the left. Shape analysis also suggested a trend towards a difference in
the left caudate in psychotic patients, who showed an increase in the dorsal head and body of
the caudate in regions connecting orbital and medial prefrontal cortex (Haber et al., 2000).
No changes were seen in the right caudate in either analysis, and there were no relationships
between duration of illness and lithium or valproate treatment and caudate shape.
The regional reductions in the left CN in bipolar patients may result from alterations to
neuronal structure at a microscopic level, which are detectable neuroradiologically at a
macroscopic level. Reductions in both glial and neuronal density have been reported in
DLPFC in BPAD (Rajkowska et al., 2001), and of GABAergic neurons in entorhinal and
anterior cingulate cortex (Pantazopoulos et al., 2007; Woo et al., 2004). It is possible that
direct striatal neuronal loss (such as the GABAergic medium spiny neuron (MSN)
population), such as that seen in Huntington’s disease, may result in surface deflation.
However, it is also possible that atrophy of the MSN dendritic arbor as a loss of reduced
dopaminergic input – such as that occurring in Parkinson’s disease (McNeill et al., 1988) –
could result in subtle volumetric differences without direct cellular loss. Thus, in the absence
of an understanding of the relationship between CN changes and those in other brain
regions, it is difficult to determine if these changes are primary pathology in the caudate, or
secondary to changes elsewhere in frontal-subcortical loops (Marchand and Yurgelun-Todd,
2010).
The trend towards a significant expansion in the left caudate head in psychotic bipolar
patients compared to non-psychotic patients raises questions as to how psychosis may result
in grey matter increases. Psychosis is described as causing both increases (Fornito et al.,
2009) and decreases (Koo et al., 2008) in grey matter volume in BPAD patients, and this has
been linked to possible overactivity of the hypothalamic-pituitary-amygdala (HPA) axis in
first-presentation psychosis (Fornito et al., 2009). However, these patients were euthymic,
non-psychotic and not actively treated for psychosis, suggesting that any HPA-linked
changes in early psychosis were unlikely to be causing these changes. Another possibility is
that patients with a previous history of psychosis may have had greater cumulative exposure
to antipsychotic medication, and in spite of the dataset being antipsychotic-free for at least
12 months prior to scanning, persistent effects of antipsychotic medication on striatal
volume cannot be ruled out (Kornhuber et al., 2006).
Our findings suggest that CN structural changes in BPAD-1 may be subtle. While
differences between patients and controls are not identified in volumetric analysis they may
be revealed by shape analysis. The results of the study showed that there is little to no effect
of adult-onset BPAD-I or medications for BPAD-I on the overall volume of CN for patients,
but that there may be shape changes in the ventral region of CN for patients. The trend level
difference in both volume and shape between patients with a history of psychosis and no
history could be due to a long-term effect of exposure to anti-psychotic medications. While
it was known that all patients had been exposed to antipsychotics, none had received
antipsychotics within the 12 months prior to scanning, although the true extent of the long-
lasting effect of typical antipsychotics is unknown (Kornhuber et al., 2006), and may be
relevant to the present findings.
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While there are many studies investigating anatomical changes in the BG in BPAD, few
studies have focused on direct comparisons between BPAD patients and a healthy control
group on the basis of CN volume. One of the few studies that is directly comparable with the
current study was by Aylward et al. (1994), who compared the CN volumes of 30 BPAD
patients and 30 age-matched controls with no family or personal history of psychiatric
illness. This study identified a significant diagnosis by sex interaction for CN volume,
suggesting that male bipolar patients had significantly larger caudate volumes bilaterally
compared to the male comparison subjects. In the current study, there were no significant
findings on the basis of diagnosis, despite similar sample sizes (30 BPAD patients and 30
HC for Aylward and 27 BPAD patients and 24 controls for this study), and age between
groups (BPAD: 39 ± 11, HC: 38 ± 9 for Aylward, and BPAD: 38 ± 11, HC: 39 ± 11 for this
study). There are several differences between the two studies which may explain the
differing findings. First, Aylward et al. (1994) used the Structured Clinicial Interview for
DSM-III-R, which did not distinguish between BPAD Type I and Type II, nor of
presentations of BPAD Not Otherwise Specified and cyclothymia, which are now thought to
exist on a ‘bipolar spectrum’ (Bader and Dunner, 2007). Earlier studies may have included a
more heterogeneous group of patients who are clinically and functionally distinct (Vieta and
Suppes, 2008). Secondly, Aylward et al.’s MRI sequences generated 5 mm thick slices,
which might otherwise be expected to reduce sensitivity to volumetric changes compared to
the 1 mm thick slices in our study.
As a result of the better resolution of our images we used a manual tracing technique which
differed in several ways. Our MRI tracing process used clearly defined anatomical
boundaries and the rostral and caudal cut-offs relied on visual inspection of the anatomy as
opposed to selecting an arbitrary number of slices after a certain landmark. This is a critical
issue given the variability of the placement of landmarks such as the junction between the
CN, nucleus accumbens and the lateral ventricles. A major challenge was defining the
border between the CN and the nucleus accumbens where artefacts and variability in
intensities forced some approximation in 6–7% of the slices per scan. Despite this issue,
intra- and interrater reliability remained high.
Volumetric ROI studies may not provide adequate functional correlates (Strakowski et al.,
2005), or afford enough sensitivity to detect subtle volumetric differences (Hwang et al.,
2006). It is argued that for ROI studies the time and labour intensiveness of manual tracing
leads to a restriction of sample sizes and makes detecting subtle differences more difficult
(Worth et al., 1997). The inclusion of shape analysis in this study extends the capacity of our
comparison to detect these subtle differences. Our shape analysis – using a robust
methodology used in studies of neurodegenerative (Gerardin et al., 2009) and psychiatric
(Levitt et al., 2009) disorders – demonstrated subtle findings not seen in the pure volumetric
analysis. Given that the CN is topographically mapped to different cortical regions that
subserve its motor, cognitive and affective roles (Draganski et al., 2008; Haber et al., 2000;
Leh et al., 2007), a shape analysis approach allows us to potentially implicate the
corticostriatal loops that relay through the CN. Bipolar patients in this study showed
reductions in caudate regions connecting dorsolateral prefrontal regions, which have been
implicated in the pathophysiology of bipolar disorder (Arnone et al., 2009; Strakowski et al.,
2005). Our findings were seen on the left side only, which is consistent with the literature
implicating left greater than right prefrontal regions (McDonald et al., 2004). This left-sided
shape change was present at trend level in the psychotic group compared to the non-
psychotic group, in regions connecting to medial frontal, orbitofrontal and prefrontal cortical
regions, consistent with studies suggesting structural change in these regions in psychotic
bipolar patients (de Azevedo-Marques Perico et al., 2011; Fornito et al., 2009; Tost et al.,
2010). While these changes are subtle and not all survived FDR correction, these findings
suggest that shape analysis is a useful adjunct to traditional ROI analysis of well-defined
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structures, particularly those whose connections are topographically arranged. When
referencing these results to other disorders in which we have used the same shape analysis
methodology, the difference maps demonstrate that the regional deflation seen in the left CN
in bipolar patients – in the order of 4–5 mm – is of a similar magnitude to regions of
significant deflation seen when patients with frontotemporal dementia (Looi et al., 2011b)
and progressive supranuclear palsy (Looi et al., 2011a) are compared to matched controls,
but less than that seen in the primary striatal degenerative disorder neuroacanthocytosis
(Walterfang et al., 2011). Additionally, the findings seen in this study are regionally much
smaller compared to analyses with neurodegenerative disorders. This suggests that these
findings represent significant, if circumscribed, neuropathology that when seen in other
disorders predicts functional impairment.
Our study has a number of limitations. Given the number of participants, it is possible that
our subgroup analyses are underpowered, leading to the possibility of type II error –
particularly so in a non-parametric analysis over more than 1000 data points per structure.
Additionally, the interrater reliability for the left caudate was < 0.85 (whereas intrarater
reliability was high), which suggests that while the between-group comparisons in this study
are likely to be valid, the comparability of the findings with those seen utilising this
methodology in other datasets may be more limited (Looi et al., 2010, 2011a, 2011b;
Walterfang et al., 2011). Furthermore, we cannot exclude that antipsychotic treatment – to
which all patients were exposed, albeit none in the year preceding scanning – affected the
results of our comparisons, potentially by attenuating between-group differences. Finally,
while we are inferring that subtle shape changes are due to microstructural alterations,
volumetric MRI technology is limited in its capacity to detect microscopic changes and it is
possible that these findings only represent the detectable ‘tip’ of a larger affected region.
Despite insights from functional, receptor and genetic studies, the pathophysiology of BPAD
is still largely incomplete. There are multiple interacting factors that do not appear to
localise to any single structure (Strakowski et al., 2005), so it is difficult to define any
particular hypotheses for our largely negative findings. It is possible that there is no baseline
change in the CNV due to BPAD-I in itself, and that volume changes in the general
population are due largely to the effects of medication, given evidence that lithium protects
against the loss of grey matter implicated in BPAD (Brambilla et al., 2001). However, given
the substantial number of patients that were taking lithium (n = 12), such an effect for
medicated subjects in the form of increased CNV was expected and the lack of result here
was surprising. Overall, the interconnected nature of the corticothalamic and limbic circuits
that include the BG and complex functional findings suggest that the relationship between
functional and neuroanatomical defects in BPAD is not direct.
We have demonstrated in a study using high-resolution MRI that gross structural changes do
not occur in the CN in BPAD-1, although there may be subtle changes detectable by shape
analysis, in regions that connect with prefrontal cortical areas that have previously been
implicated in the disorder.
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Example of manually traced boundaries of caudate nucleus on coronal slice of MRI scan on
left; on right, anterior (top right) and posterior (bottom right) margins of the caudate
nucleus..
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The SPHARM process and analysis. On left, binarised image is pre-processed and
smoothed. Centre, image is converted to surface meshes, and a spherical parameterisation is
computed for the surface mesh, and meshes are aligned to establish correspondence across
all surfaces. Right, group differences are computed using Hotelling T2 sample metric, and
significance maps computed for each analysis, both raw uncorrected p-value maps and FDR-
corrected maps.
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Significance maps for comparison between bipolar patients and controls for left caudate,
with areas in blue indicating regions where p > 0.05. Top row shows dorsomedial aspect,
bottom row ventrolateral. On left, raw uncorrected p-value maps; middle, FDR-corrected p-
value maps; right, mean difference maps in mm.
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Significance maps for comparison between bipolar patients and controls for right caudate.
Top row shows dorsomedial aspect, bottom row ventrolateral. On left, raw uncorrected p-
value maps; middle, FDR-corrected p-value maps; right, mean difference maps in mm.
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Significance maps for comparison between psychotic and non-psychotic bipolar patients for
left caudate. Top row shows dorsomedial aspect, bottom row ventrolateral. On left, raw
uncorrected p-value maps; middle, FDR-corrected p-value maps; right, mean difference
maps in mm.
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Significance maps for comparison between psychotic and non-psychotic bipolar patients for
right caudate. Top row shows dorsomedial aspect, bottom row ventrolateral. On left, raw
uncorrected p-value maps; middle, FDR-corrected p-value maps; right, mean difference
maps in mm.
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Table 1
Demographic data for patient groups, displayed as means/standard deviations, or numbers of subgroups.
Controls (n = 24) Bipolar (n = 27) Variable p
Age at scan (years) 38.67 ± 11.07 38.38 ± 10.87 t = 0.091 0.93
Gender (M/F) 7/17 8/19 χ2 = 0.001 0.97
Current NART-IQ 115.08 ± 9.59 113.80 ± 7.13 t = 0.53 0.60
Education level (years) 14.58 ± 2.10 14.64 ± 2.83 t = −0.080 0.94
Age at illness onset (years) 24.88 ± 8.37
Illness duration (years) 13.50 ± 10.13
Lifetime manic episodes 8.85 ± 10.17
Lifetime depressive episodes 11.12 ± 10.77
History of psychosis (Y/N) 16/11
Family history (BP/UP/BUP/N/U) 3/5/2/11/5
Medication at scan time(LI/VAL/CBZ/LIVAL/VALCBZ/MF/U) 8/7/1/4/5/1
NART: National Adult Reading Test; IQ: intelligence quotient.
For family history, BP: family history of bipolar disorder; UP: unipolar depression; BUP: both bipolar disorder and unipolar depression; N: no
family history; U: unknown.
For medication at scan time, LI: lithium; VAL: valproate; CBZ: carbamazepine; LIVAL: both lithium and valproate; VALCBZ: both valproate and
carbamazepine; MF: medication free; U: unknown.
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Table 2
Means for intracranial volume and left/right caudate volume for control and bipolar groups.
Controls (n = 24) Bipolar (n = 27) t p
Intracranial volume (× 106 mm3) 1.461 ± 0.148 1.475 ± 0.123 −0.364 0.72
Right caudate volume (mm3) 3779 ± 476 3836 ± 522 −0.410 0.68
Left caudate volume (mm3) 3876 ± 431 3926 ± 506 −0.377 0.71
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Table 3
Significance (expressed as p-values) for overall group surface comparisons.
p
Left caudate Right caudate
Bipolar vs controls 0.028* 0.193
Psychotic vs non-psychotic bipolar 0.096** 0.211
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